Search

everythinglearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Enhancing immune response can improve cancer treatment effectiveness.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Mogamulizumab can cause hair loss and skin rashes.

Blocking IL-8 can reduce skin rashes from cancer treatment.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

A patient with complete hair loss regrew all her hair using tofacitinib.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.